A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Cherie Ann O NathanDavid Neil HayesTheodore KarrisonOlivier HarismendyJosé M FloresTara Moore-MedlinEverett E VokesJorge Silvio GutkindPrakash NeupaneGlenn MillsZoukaa SargiTanguy SeiwertJuneko E Grilley OlsonTerry A DayMaura L GillisonJames L WadeLawrence E FeldmanGautam JhaMark KozloffMiriam O'LearyFrancis P WordenEzra E W CohenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
p16-negative and TP53mut patients may benefit from adjuvant treatment with everolimus.